EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
1.3.1.48 | (13E)-11alpha-hydroxy-9,15-dioxoprost-13-enoate + NADPH + H+ |
- |
Homo sapiens |
11alpha-hydroxy-9,15-dioxoprostanoate + NADP+ |
- |
? |
1.3.1.48 | (5S,12R)-dihydroxy-(6E,8Z,10Z,14E)-eicosatetraenoic acid + NADH |
15-keto-prostaglandin-13-reductase activity is 200fold higher than leukotrien B4-12hydroxydehydrogenase activity |
Cavia porcellus |
? |
- |
? |
1.3.1.48 | (5S,12R)-dihydroxy-(6E,8Z,10Z,14E)-eicosatetraenoic acid + NADH |
trivial name leukotriene B4, enzyme exhibits a 15-ketoprostaglandin-13-reductase and a very low leukotriene B4 12-hydroxydehydrogenase activity |
Sus scrofa |
? |
- |
? |
1.3.1.48 | (5S,6R)-dihydroxy-15-oxo-(7E,9E,11Z,13E)-eicosatetraenoic acid + NADH |
trivial name 15-oxo-lipoxin A4 |
Sus scrofa |
13,14-dihydro-(5S,6R)-dihydroxy-15-oxo-(7E,9E,11Z)-eicosatetraenoic acid + NAD+ |
- |
? |
1.3.1.48 | (5Z,13E)-11alpha-hydroxy-9,15-dioxoprost-5,13-dienoate + NAD(P)H |
- |
Gallus gallus |
(5Z)-11alpha-hydroxy-9,15-dioxoprost-5-enoate + NAD(P)+ |
- |
ir |
1.3.1.48 | (5Z,13E)-11alpha-hydroxy-9,15-dioxoprost-5,13-dienoate + NAD(P)H |
- |
Homo sapiens |
(5Z)-11alpha-hydroxy-9,15-dioxoprost-5-enoate + NAD(P)+ |
- |
ir |
1.3.1.48 | (5Z,13E)-11alpha-hydroxy-9,15-dioxoprost-5,13-dienoate + NAD(P)H |
- |
Rattus norvegicus |
(5Z)-11alpha-hydroxy-9,15-dioxoprost-5-enoate + NAD(P)+ |
- |
? |
1.3.1.48 | (5Z,13E)-11alpha-hydroxy-9,15-dioxoprost-5,13-dienoate + NAD(P)H |
- |
Sus scrofa |
(5Z)-11alpha-hydroxy-9,15-dioxoprost-5-enoate + NAD(P)+ |
- |
ir |
1.3.1.48 | (5Z,13E)-11alpha-hydroxy-9,15-dioxoprost-5,13-dienoate + NAD(P)H |
- |
Bos taurus |
(5Z)-11alpha-hydroxy-9,15-dioxoprost-5-enoate + NAD(P)+ |
- |
ir |
1.3.1.48 | (5Z,13E)-11alpha-hydroxy-9,15-dioxoprost-5,13-dienoate + NAD(P)H |
no substrates: 15-hydroxyprostaglandins, progesterone, cortisone, orotic acid, fumaric acid |
Homo sapiens |
(5Z)-11alpha-hydroxy-9,15-dioxoprost-5-enoate + NAD(P)+ |
- |
? |